XML 64 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Long-Term Investments (Details 4) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Net sales $ 197,733 $ 747 $ 601,757 $ 3,976
Gross Profit 194,936 210 584,109 1,120
Net loss (1,329,685) (687,300) (2,817,454) (2,136,962)
Share of losses from investments accounted for using the equity method $ (201,590) (287,513)
Rgene Corporation [Member]        
Net sales    
Gross Profit    
Net loss     (59,717) (191,534)
Share of losses from investments accounted for using the equity method    
BioFirst Corporation [Member]        
Net sales     32,235 33,304
Gross Profit     5,048 6,590
Net loss     (842,838) (766,425)
Share of losses from investments accounted for using the equity method     $ (182,113) $ (164,649)